Oncology
- Business
Malawi First Lady Joins Merck Foundation First Ladies Summit via Videoconference to Discuss Healthcare Capacity and COVID-19 Response in Africa
Lilongwe, Malawi & Mumbai, Maharashtra, India: Merck Foundation appoints Malawi First Lady as the Ambassador of Merck More Than a…
Read More » - Technology
PierianDx and Pillar Biosciences Announce Partnership to Support Precision Cancer Care
St. Louis, Natick, Mass., United States: PierianDx, the leading clinical genomics informatics company, and Pillar Biosciences, a leading next-generation sequencing…
Read More » - Health
Boehringer Ingelheim and Oxford BioTherapeutics Expand Collaboration to Discover Novel Selective Tumor Targets as First Bispecific Antibody Advanced into the Clinic
Oxford, England & Ingelheim, Germany: The collaboration for the discovery of novel selective tumor targets for Boehringer Ingelheim’s unique T-cell…
Read More » - Technology
Takeda Accelerates Digital Transformation with Accenture and AWS
Osaka, Japan & Seattle, New York, United States: Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) (“Takeda”), Accenture (NYSE: ACN) and…
Read More » - Health
Safety and Efficacy of Subcutaneous Entyvio® (Vedolizumab) Sustained During Long-term Maintenance Therapy in Adults with Moderately to Severely Active Ulcerative Colitis
Osaka, Japan: Interim analysis from VISIBLE OLE study showed long-term findings consistent with the known safety profile of vedolizumab with…
Read More » - United States
Takeda and Arrowhead Collaborate to Co-Develop and Co-Commercialize ARO-AAT for Alpha-1 Antitrypsin-Associated Liver Disease
Japan & United States: − Potential first-in-class therapy designed to treat the underlying cause of liver disease associated…
Read More » - India
World’s First Integrative Oncology Healthtech Platform, ZenOnco.io, Recognized at ESMO for its Artificial Intelligence-Based Free Cancer Treatment Guidance
Mumbai, Maharashtra, India: ZenOnco.io, the World’s First Integrative Oncology healthtech platform, has received global recognition at the European Society for Medical…
Read More » - Health
Boehringer Ingelheim Advances Novel Bi-specific TRAILR2/CDH17 Antibody to Phase 1 Clinical Trial for Patients Living with Gastrointestinal Cancers
Ingelheim, Germany: First-in-class bi-specific antibody BI 905711 activates a pathway in TRAILR2 and CDH17 co-expressing tumor cells that leads to…
Read More » - India
Central Government’s Chittaranjan National Cancer Institute (CNCI) starts its OPD services from its new campus at Rajarhat, Kolkata
The Chittaranjan National Cancer Institute has started its OPD services from its new campus at Rajarhat, Kolkata from 19th August,…
Read More »